A company presents its adjusted EBITDA, which excludes Rs 12 crore of “exceptional items”: Rs 5 crore of restructuring costs, Rs 4 crore of impairment charges and Rs 3 crore of acquisition-related expenses.
The adjustments are individually reasonable. The restructuring was a genuine organisational change. The impairment reflected a specific asset’s deterioration. The acquisition costs are related to a completed transaction.
The question is not whether each item is individually exceptional. It is whether the pattern of exceptional items, taken across multiple years, is itself normal.
Review the last five years: restructuring costs in Year 1, Year 3 and Year 5. Impairment charges in Year 2, Year 4 and Year 5. Acquisition costs in Year 2, Year 3 and Year 5. “Exceptional” items appeared in every year. The total ranged from Rs 8 crore to Rs 15 crore annually. The average was Rs 11 crore.
If a company incurs Rs 11 crore of “exceptional” items every year, the items are not exceptional. They are a normal cost of running the business. Excluding them from EBITDA creates a metric that overstates the company’s sustainable earnings by Rs 11 crore, which at a 10x multiple is Rs 110 crore of enterprise value attributed to items the company’s own definition says should not count.
When “One-Off” Becomes Recurring
Restructuring every cycle
A company that restructures its operations every 18 to 24 months, each time classifying the cost as exceptional, is not incurring one-off costs. It is operating a business model that requires periodic restructuring, and the restructuring cost is part of the model’s operating cost.
Serial impairments
A company that impairs an asset or an investment every year is not experiencing exceptional asset deterioration. It is experiencing a pattern of value destruction that its capital allocation or impairment testing has failed to prevent or recognise on time.
Recurring acquisition costs
A company that acquires businesses regularly incurs advisory fees, integration costs and deal expenses as part of its growth strategy. Excluding these costs from operating performance treats the company’s chosen growth mechanism as if it were costless.
Litigation settlements every year
A company in a regulated industry that settles litigation or pays regulatory penalties every year is not incurring exceptional legal costs. It is operating in an environment where legal cost is a recurring operational expense.
The Test
In Northrop Management Private Limited’s forensic and financial advisory work, the “One-Off” Expense Test applies a simple, rigorous standard.
Step 1: List every item classified as exceptional, one-off, non-recurring or excluded from adjusted EBITDA for each of the last five years.
Step 2: For each item, determine: has a similar item occurred before? “Similar” means the same category (restructuring, impairment, litigation, acquisition costs), not the same specific event. An impairment of Division A in Year 2 and an impairment of Division B in Year 4 are both impairments. The specific asset differs. The cost category recurs.
Step 3: Calculate the annual average of “exceptional” items over five years.
Step 4: Add the annual average back to the company’s adjusted EBITDA. The result is the “truly adjusted” EBITDA: operating performance including the recurring cost of items that management classifies as exceptional.
Step 5: Recalculate the valuation. The enterprise value based on truly adjusted EBITDA is lower than the value based on management’s adjusted EBITDA, by a multiple of the annual average of recurring “exceptional” items.
The gap between management’s adjusted EBITDA and truly adjusted EBITDA is the overstatement premium: the amount by which the company’s preferred metric exceeds its sustainable earnings.
Ashish Chaudhary, frames the analytical standard directly: “If an ‘exceptional’ item keeps appearing, the question is no longer whether it is unusual. It is whether management’s definition of normal is useful. A company that excludes Rs 11 crore per year of costs that occur in some form every year has not identified exceptional items. It has defined ‘normal’ in a way that excludes a meaningful portion of its actual cost base.”
Questions for the Boardroom
- What is the total value of items classified as exceptional, non-recurring or excluded from adjusted EBITDA in each of the last five years?
- How many of those items have recurred (in the same category, if not the same specific event) across multiple years?
- What is the five-year annual average of “exceptional” items, and if we add that average back to adjusted EBITDA, how does the valuation change?
- Is our executive compensation based on adjusted EBITDA that excludes recurring “exceptional” items?
- If an investor applied our own exceptional-item classifications over a five-year period and calculated the recurrence rate, would they conclude that our definition of “exceptional” is credible?
Closing Implication
An exceptional item is a cost that the business does not normally incur. If the business incurs costs in the same category every year, or in most years, the category is not exceptional. It is operational. Excluding it from operating performance creates a metric that describes a company with lower costs than it actually faces, and a valuation based on that metric overpays for a cost structure that does not exist.